Sevoflurane Alleviates Myocardial Ischemia/Reperfusion Injury by Targeting the circ_CDR1as/miR‐671‐5p/HMGA1 Axis
Journal of Biochemical and Molecular Toxicology · 2025-01 · 39 (1)
DOI: 10.1002/jbt.70094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 24.12.2024. Verfasst von Zhengnan Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Geriatric Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Sevoflurane, MicroRNAs, Myocardial Reperfusion Injury, HMGA1a Protein. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Sevoflurane (Sev) has a cardioprotective role in myocardial ischemia/reperfusion injury (MI/RI), but its mechanism has not been fully elucidated. This study aimed to investigate whether the circ_CDR1as/miR‐671‐5p/HMGA1 axis mediates the cardioprotective effect of Sev in MI/RI. Cardiomyocytes underwent hypoxia/reoxygenation (H/R) treatment was used to simulate MI/RI in vitro. H/R cardiomyocytes were then pretreated with Sev to explore the protective effect of Sev on H/R cells. The level of CDR1as/miR‐671‐5p/HMGA1 axis were detected by RT‐qPCR. The proliferation and apoptosis of cardiomyocytes were detected by CCK‐8 and flow cytometry. The levels of myocardial injury markers and inflammatory markers were detected by ELISA assay. Finally, the regulatory relationship between CDR1as and miR‐671‐5p/HMGA1 axis was verified by Dual‐luciferase reporting and RNA pull‐down assays. Sev Pretreatment can reduce the level of CDR1as and mitigate H/R‐induced damage to cardiomyocytes. This Pretreatment lowers the levels of myocardial injury markers, oxidative stress markers, and pro‐inflammatory factors in H/R‐affected cardiomyocytes. However, CDR1as overexpression inhibits Sev's protective effect on H/R cardiomyocytes. At the molecular mechanism, we found that CDR1as mediates Sev's protective effect through the CDR1as/miR‐671‐5p/HMGA1 axis. CDR1as increases HMGA1 levels by sponging miR‐671‐5p, while high HMGA1 levels diminish Sev's protective effect. Sev plays a cardioprotective role in MI/RI by inhibiting the circ_CDR1as/miR‐671‐5p/HMGA1 axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Geriatric Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
- Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.
- Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, China.
- Intensive Care Unit, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Zitieren
APA
Zhang, Z., Yang, X., Feng, B., & Huang, H. (2025). Sevoflurane Alleviates Myocardial Ischemia/Reperfusion Injury by Targeting the circ_CDR1as/miR‐671‐5p/HMGA1 Axis. Journal of Biochemical and Molecular Toxicology, 39(1). https://doi.org/10.1002/jbt.70094
Vancouver
Zhang Z, Yang X, Feng B, Huang H. Sevoflurane Alleviates Myocardial Ischemia/Reperfusion Injury by Targeting the circ_CDR1as/miR‐671‐5p/HMGA1 Axis. Journal of Biochemical and Molecular Toxicology. 2025;39(1). doi:10.1002/jbt.70094
BibTeX
@article{Zhang2025,
author = {Zhang, Zhengnan and Yang, Xi and Feng, Baihe and Huang, Haibin},
title = {Sevoflurane Alleviates Myocardial Ischemia/Reperfusion Injury by Targeting the circ_CDR1as/miR‐671‐5p/HMGA1 Axis},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
volume = {39},
number = {1},
doi = {10.1002/jbt.70094}
}
EUVIMED